Moderna's coronavirus vaccine could get UK approval within two weeks after a final analysis of its late-stage trial showed it was 94.1% effective with no serious safety concerns.
The American biotech company has submitted its coronavirus vaccine for US emergency authorisation, and its application will be considered by regulators on December 17.
It is also submitting its data to regulators in the UK and Europe for an emergency licence, and a British expert says it could receive UK approval by mid-December.
The UK Government has ordered another two doses of the Covid-19 vaccine, bringing the total number of jabs on order to seven million.